Connect Investigative Site 307 — New Albany, Indiana

Connect Investigative Site 307 is a clinical research site located in New Albany, Indiana, United States 47150.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Connect Investigative Site 307 has participated in 1 clinical trials.

Therapeutic areas: Moderate-to-severe Atopic Dermatitis.

Sponsors: Connect Biopharm LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Connect Investigative Site 307?

Connect Investigative Site 307 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Connect Investigative Site 307 conducted?

Connect Investigative Site 307 has 1 clinical trials on record. Their work covers Moderate-to-severe Atopic Dermatitis.

Is Connect Investigative Site 307 accredited by Crixeo Health?

Connect Investigative Site 307 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Connect Investigative Site 307?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.